Literature DB >> 16962827

Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients.

Daniele Moratto1, Anna Virginia Gulino, Stefania Fontana, Luigi Mori, Silvia Pirovano, Annarosa Soresina, Antonella Meini, Luisa Imberti, Luigi Daniele Notarangelo, Alessandro Plebani, Raffaele Badolato.   

Abstract

Common variable immunodeficiency disease (CVID) is a primary immune disorder affecting B cells and characterized by hypogammaglobulinemia and recurrent infections. To elucidate the clinical and immunological heterogeneity of this condition, we have studied B and T cell subsets in 25 CVID patients. In eleven of them, we observed a remarkable relative expansion of a B cell subpopulation (CD19(hi)/CD21(lo) cells) characterized by the absence of CD23 and the reduced expression of the chemokine receptors CXCR5 and CCR7. Our analyses demonstrated in these patients that the expansion of CD19(hi)/CD21(lo) cells correlates with a selective decrease of circulating naïve and CD21(hi) memory B lymphocytes. The same group of patients displayed a simultaneous severe reduction of naïve CD4+ T cells associated with decreased levels of T cell receptor excision circles. These observations suggest that a combined defect in generation of B and T subpopulations may account for the abnormal immunophenotype characterizing this subgroup of CVID patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962827     DOI: 10.1016/j.clim.2006.07.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  19 in total

1.  LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency.

Authors:  Abdullah Alangari; Abdulrahman Alsultan; Nouran Adly; Michel J Massaad; Iram Shakir Kiani; Abdulrahman Aljebreen; Emad Raddaoui; Abdul-Kareem Almomen; Saleh Al-Muhsen; Raif S Geha; Fowzan S Alkuraya
Journal:  J Allergy Clin Immunol       Date:  2012-06-19       Impact factor: 10.793

2.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

3.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

4.  Thymic and bone marrow output in patients with common variable immunodeficiency.

Authors:  Federico Serana; Paolo Airò; Marco Chiarini; Cinzia Zanotti; Mirko Scarsi; Micol Frassi; Vassilios Lougaris; Alessandro Plebani; Luigi Caimi; Luisa Imberti
Journal:  J Clin Immunol       Date:  2011-04-14       Impact factor: 8.317

5.  Defective functions of polymorphonuclear neutrophils in patients with common variable immunodeficiency.

Authors:  Sarah Casulli; Hélène Coignard-Biehler; Karima Amazzough; Michka Shoai-Tehrani; Jagadeesh Bayry; Nizar Mahlaoui; Carole Elbim; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

6.  B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease.

Authors:  Gaël Mouillot; Maryvonnick Carmagnat; Laurence Gérard; Jean-Luc Garnier; Claire Fieschi; Nicolas Vince; Lionel Karlin; Jean-François Viallard; Roland Jaussaud; Julien Boileau; Jean Donadieu; Martine Gardembas; Nicolas Schleinitz; Felipe Suarez; Eric Hachulla; Karen Delavigne; Martine Morisset; Serge Jacquot; Nicolas Just; Lionel Galicier; Dominique Charron; Patrice Debré; Eric Oksenhendler; Claire Rabian
Journal:  J Clin Immunol       Date:  2010-05-01       Impact factor: 8.317

7.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.

Authors:  Mirzokhid Rakhmanov; Baerbel Keller; Sylvia Gutenberger; Christian Foerster; Manfred Hoenig; Gertjan Driessen; Mirjam van der Burg; Jacques J van Dongen; Elisabeth Wiech; Marcella Visentini; Isabella Quinti; Antje Prasse; Nadine Voelxen; Ulrich Salzer; Sigune Goldacker; Paul Fisch; Hermann Eibel; Klaus Schwarz; Hans-Hartmut Peter; Klaus Warnatz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-29       Impact factor: 11.205

8.  CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Authors:  Necil Kutukculer; Elif Azarsiz; Guzide Aksu; Neslihan Edeer Karaca
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

9.  Ex vivo γ-retroviral gene therapy of dogs with X-linked severe combined immunodeficiency and the development of a thymic T cell lymphoma.

Authors:  Douglas R Kennedy; Brian J Hartnett; Jeffrey S Kennedy; William Vernau; Peter F Moore; Thomas O'Malley; Linda C Burkly; Paula S Henthorn; Peter J Felsburg
Journal:  Vet Immunol Immunopathol       Date:  2011-04-14       Impact factor: 2.046

10.  Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.

Authors:  B Fevang; A Yndestad; J K Damås; B Halvorsen; A M Holm; K Beiske; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2009-08-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.